About Standard Bots Standard Bots builds AI-native industrial robot arms deployed at manufacturing facilities across the U.S. In June 2026 we closed a $200M Series C at a $1B valuation, led by RoboStrategy with continued backing from
At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered